Search Results - "Yasunori Hoshiya"

Mullerian-Inhibiting Substance Regulates NF-κB Signaling in the Prostate in vitro and in vivo by Segev, Dorry L., Hoshiya, Yasunori, Hoshiya, Makiko, Tran, Trinh T., Carey, Jennifer L., Stephen, Antonia E., MacLaughlin, David T., Donahoe, Patricia K., Maheswaran, Shyamala

“…Mullerian-inhibiting substance (MIS) is a member of the transforming growth factor β superfamily, a class of molecules that regulates growth, differentiation,…”
Get full text

Pharmacokinetics ofcis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions by Kurihara, Naoto, Kubota, Tetsuro, Hoshiya, Yasunori, Otani, Yoshihide, Ando, Nobutoshi, Kumai, Koichiro, Kitajima, Masaki

Get full text

Antitumor activity of cis-diamminedichloroplatinum II against human tumor xenografts depends on its area under the curve in nude mice by Kurihara, Naoto, Kubota, Tetsuro, Hoshiya, Yasunori, Otani, Yoshihide, Watanabe, Masahiko, Kumai, Koichiro, Kitajima, Masaki

“…A pharmacodynamic analysis of cis‐diamminedichloroplatinum(II) (DDP) was conducted using two human gastric cancer xenografts, SC‐1‐NU and MKN‐45, and one human…”
Get full text

Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression by Clarke, T R, Hoshiya, Y, Yi, S E, Liu, X, Lyons, K M, Donahoe, P K

“…Signal reception of Müllerian inhibiting substance (MIS) in the mesenchyme around the embryonic Müllerian duct in the male is essential for regression of the…”
Get full text

Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells by Hoshiya, Yasunori, Gupta, Vandana, Segev, Dorry L., Hoshiya, Makiko, Carey, Jennifer L., Sasur, Laura M., Tran, Trinh T., Ha, Thanh U., Maheswaran, Shyamala

“…The MIS type II receptor is expressed at high levels in the Mullerian duct and in Sertoli cells and granulosa cells of the embryonic and adult gonads. The…”
Get full text

Müllerian Inhibiting Substance Regulates NFκB Signaling and Growth of Mammary Epithelial Cells in Vivo by Segev, Dorry L., Hoshiya, Yasunori, Stephen, Antonia E., Hoshiya, Makiko, Tran, Trinh T., MacLaughlin, David T., Donahoe, Patricia K., Maheswaran, Shyamala

“…Müllerian inhibiting substance (MIS) inhibits breast cancer cell growth in vitro through interference with cell cycle progression and induction of apoptosis, a…”
Get full text

Mullerian Inhibiting Substance Promotes Interferon γ-induced Gene Expression and Apoptosis in Breast Cancer Cells by Hoshiya, Yasunori, Gupta, Vandana, Kawakubo, Hirofumi, Brachtel, Elena, Carey, Jennifer L., Sasur, Laura, Scott, Andrew, Donahoe, Patricia K., Maheswaran, Shyamala

“…This report demonstrates that in addition to interferons and cytokines, members of the TGFβ superfamily such as Mullerian inhibiting substance (MIS) and…”
Get full text

Mullerian-inhibiting substance regulates NF-kappaB signaling in the prostate in vitro and in vivo by Segev, Dorry L, Hoshiya, Yasunori, Makiko Hoshiya Trinh T Tran

“…Mullerian-inhibiting substance (MIS) is a member of the transforming growth factor beta superfamily, a class of molecules that regulates growth,…”
Get full text

Mullerian Inhibiting Substance Promotes Interferon γ-induced Gene Expression and Apoptosis in Breast Cancer Cells by Yasunori Hoshiya, Vandana Gupta, Hirofumi Kawakubo, Elena Brachtel, Jennifer L. Carey, Laura Sasur, Andrew Scott, Patricia K. Donahoe, Shyamala Maheswaran

“…This report demonstrates that in addition to interferons and cytokines, members of the TGFβ superfamily such as Mullerian inhibiting substance (MIS) and…”
Get full text

Methionine-depletion modulates the efficacy of 5-fluorouracil in human gastric cancer in nude mice by Hoshiya, Y, Kubota, T, Inada, T, Kitajima, M, Hoffman, R M

“…Human tumors are generally methionine (MET)-dependent in that their growth is inhibited by MET-depletion down to levels that will still allow normal cell…”
Get more information

Methionine starvation modulates the efficacy of cisplatin on human breast cancer in nude mice by Hoshiya, Y, Kubota, T, Matsuzaki, S W, Kitajima, M, Hoffman, R M

“…There are few agents with activity against metastatic breast cancer. We therefore exploited the elevated methionine dependence of tumors to develop a selective…”
Get more information

Müllerian Inhibiting Substance Regulates NFκB Signaling and Growth of Mammary Epithelial Cells in Vivo by Dorry L. Segev, Yasunori Hoshiya, Antonia E. Stephen, Makiko Hoshiya, Trinh T. Tran, David T. MacLaughlin, Patricia K. Donahoe, Shyamala Maheswaran

“…Müllerian inhibiting substance (MIS) inhibits breast cancer cell growth in vitro through interference with cell cycle progression and induction of apoptosis,…”
Get full text

Pharmacokinetics of cis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions by Kurihara, Naoto, Kubota, Tetsuro, Hoshiya, Yasunori, Otani, Yoshihide, Ando, Nobutoshi, Kumai, Koichiro, Kitajima, Masaki

“…A pharmacokinetic analysis of cis‐diamminedichloroplatinum (II) (DDP) was conducted comparing low‐dose daily bolus infusions, and high‐dose drip infusions…”
Get full text

Müllerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 Expression by Clarke, Trent R, Hoshiya, Yasunori, Yi, Soyun E, Liu, Xiaohong, Lyons, Karen M, Donahoe, Patricia K

“…Signal reception of Müllerian inhibiting substance (MIS) in the mesenchyme around the embryonic Müllerian duct in the male is essential for regression of the…”
Get full text

Antitumor activity of cis-diamminedichloroplatinum (II) against human tumor xenografts depends on its area under the curve in nude mice by KURIHARA, N, KUBOTA, T, HOSHIYA, Y, OTANI, Y, WATANABE, M, KUMAI, K, KITAJIMA, M

Get full text

Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice by Kubota, Tetsuro, Matsuzaki, Shinjiro Wilson, Hoshiya, Yasunori, Watanabe, Masahiko, Kitajima, Masaki, Asanuma, Fumiki, Yamada, Yoshinori, Koh, Jun-Ichi

“…Background Paclitaxel (BMS‐181339: Taxol) is a promising agent against previously treated breast cancer. The antitumor activity of paclitaxel was evaluated…”
Get full text